Cookies used for improved website experience

Siemens Healthineers and our partners use cookies and other similar technologies to operate the Siemens Healthineers websites and personalize content and ads. You may find out more about how we use cookies by clicking "Show details" or by referring to our Cookie Policy.
You may allow all cookies or select them individually. And you may change your consent and cookie preferences anytime by clicking on the "Review and change your consent" button on the Cookie Policy page.

kFLC in CSF as a diagnostic marker for multiple sclerosis

In this webinar, Dr. Skripuletz focuses on the growing evidence for the utility and value of the kappa free light chain index (kFLC index) in cerebrospinal fluid (CSF) for diagnosis and management of multiple sclerosis (MS). Recommendations on the use of the kFLC index in MS patients are also provided.

Thomas Skripuletz, Medizinische Hochschule Hannover

Dr. Thomas Skripuletz
Medizinische Hochschule
Hannover, Germany